Vetoquinol S.A.
VETO.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$902.07M
Close$
$77.07
1.3% downside
Current Fair Value
1.3% downsideOvervalued by 1.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $902.07 Million |
|---|---|
| Enterprise Value | $679.22 Million |
| Dividend Yield | $0.93 (1.20%) |
| Earnings per Share | $4.94 |
| Beta | 0.83 |
| Outstanding Shares | 11,882,000 |
Return
| Return on Equity | 20.15% |
|---|---|
| Return on Assets | 15.92% |
| Return on Invested Capital | 63.14% |
Valuation & Multiples
| P/E Ratio | 14.59 |
|---|---|
| PEG | 67.47 |
| Price to Sales | 0.88 |
| Price to Book Ratio | 1.53 |
| Enterprise Value to Revenue | 0.64 |
| Enterprise Value to EBIT | 1.71 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$125.70 M
Average shareholder expectationNext Earnings Call
Expected Date
March 25, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$257.41 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Vetoquinol S.A.
2,501 employees
CEO: Matthieu Frechin Vetoquinol S.A. is a pharmaceutical company dedicated to animal health, responsible for researching, formulating, and distributing veterinary medicines and other health-related products throughout Europe, the Americas, and the Asia Pacif...